nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—HPD—Phenylalanine and tyrosine catabolism—TAT—liver cancer	0.456	0.66	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—TAT—liver cancer	0.0401	0.058	CbGpPWpGaD
Nitisinone—Flutamide—AHR—liver cancer	0.0296	0.763	CrCbGaD
Nitisinone—HPD—Amino acid and derivative metabolism—GLUL—liver cancer	0.0272	0.0394	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PSMA4—liver cancer	0.0156	0.0226	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PSMD10—liver cancer	0.0156	0.0226	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—GOT2—liver cancer	0.0152	0.022	CbGpPWpGaD
Nitisinone—Septicemia—Epirubicin—liver cancer	0.0139	0.0514	CcSEcCtD
Nitisinone—HPD—Amino acid and derivative metabolism—GOT1—liver cancer	0.0131	0.019	CbGpPWpGaD
Nitisinone—Septicemia—Doxorubicin—liver cancer	0.0129	0.0475	CcSEcCtD
Nitisinone—Neoplasm malignant—Sorafenib—liver cancer	0.00999	0.037	CcSEcCtD
Nitisinone—Flutamide—CYP1A1—liver cancer	0.00917	0.237	CrCbGaD
Nitisinone—HPD—Metabolism—UGDH—liver cancer	0.00825	0.0119	CbGpPWpGaD
Nitisinone—HPD—Metabolism—EPT1—liver cancer	0.00776	0.0112	CbGpPWpGaD
Nitisinone—HPD—Metabolism—TAT—liver cancer	0.00736	0.0106	CbGpPWpGaD
Nitisinone—Hepatic function abnormal—Sorafenib—liver cancer	0.00709	0.0262	CcSEcCtD
Nitisinone—Hepatic failure—Sorafenib—liver cancer	0.00689	0.0255	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Sorafenib—liver cancer	0.00657	0.0243	CcSEcCtD
Nitisinone—Dehydration—Sorafenib—liver cancer	0.00576	0.0213	CcSEcCtD
Nitisinone—Dry skin—Sorafenib—liver cancer	0.00568	0.021	CcSEcCtD
Nitisinone—Gastritis—Sorafenib—liver cancer	0.00548	0.0203	CcSEcCtD
Nitisinone—HPD—Metabolism—GLUL—liver cancer	0.005	0.00724	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CPT1B—liver cancer	0.005	0.00724	CbGpPWpGaD
Nitisinone—Keratitis—Epirubicin—liver cancer	0.00486	0.018	CcSEcCtD
Nitisinone—HPD—Metabolism—NR1H4—liver cancer	0.00482	0.00698	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTA3—liver cancer	0.00474	0.00686	CbGpPWpGaD
Nitisinone—Epistaxis—Sorafenib—liver cancer	0.0045	0.0167	CcSEcCtD
Nitisinone—Keratitis—Doxorubicin—liver cancer	0.0045	0.0166	CcSEcCtD
Nitisinone—Hepatomegaly—Epirubicin—liver cancer	0.00446	0.0165	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTA4—liver cancer	0.00434	0.00627	CbGpPWpGaD
Nitisinone—Haemoglobin—Sorafenib—liver cancer	0.00431	0.0159	CcSEcCtD
Nitisinone—Haemorrhage—Sorafenib—liver cancer	0.00429	0.0159	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTA2—liver cancer	0.00422	0.00611	CbGpPWpGaD
Nitisinone—Hepatomegaly—Doxorubicin—liver cancer	0.00412	0.0152	CcSEcCtD
Nitisinone—Rash erythematous—Epirubicin—liver cancer	0.00412	0.0152	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTA1—liver cancer	0.00408	0.0059	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NAT2—liver cancer	0.00403	0.00583	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ALDOB—liver cancer	0.00386	0.00559	CbGpPWpGaD
Nitisinone—Rash erythematous—Doxorubicin—liver cancer	0.00381	0.0141	CcSEcCtD
Nitisinone—Alopecia—Sorafenib—liver cancer	0.00379	0.014	CcSEcCtD
Nitisinone—Neoplasm malignant—Epirubicin—liver cancer	0.00369	0.0137	CcSEcCtD
Nitisinone—HPD—Metabolism—CRABP1—liver cancer	0.00369	0.00534	CbGpPWpGaD
Nitisinone—Amenorrhoea—Epirubicin—liver cancer	0.00359	0.0133	CcSEcCtD
Nitisinone—Neoplasm malignant—Doxorubicin—liver cancer	0.00342	0.0126	CcSEcCtD
Nitisinone—Leukopenia—Sorafenib—liver cancer	0.00334	0.0124	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—liver cancer	0.00332	0.0123	CcSEcCtD
Nitisinone—HPD—Metabolism—HPGDS—liver cancer	0.00322	0.00466	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00315	0.0117	CcSEcCtD
Nitisinone—Melaena—Epirubicin—liver cancer	0.00308	0.0114	CcSEcCtD
Nitisinone—Infection—Sorafenib—liver cancer	0.00302	0.0112	CcSEcCtD
Nitisinone—Thrombocytopenia—Sorafenib—liver cancer	0.00298	0.011	CcSEcCtD
Nitisinone—Skin disorder—Sorafenib—liver cancer	0.00296	0.0109	CcSEcCtD
Nitisinone—HPD—Metabolism—PSMD10—liver cancer	0.00287	0.00416	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PSMA4—liver cancer	0.00287	0.00416	CbGpPWpGaD
Nitisinone—Rash maculo-papular—Epirubicin—liver cancer	0.00287	0.0106	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—liver cancer	0.00285	0.0105	CcSEcCtD
Nitisinone—HPD—Metabolism—GOT2—liver cancer	0.00279	0.00404	CbGpPWpGaD
Nitisinone—Sepsis—Epirubicin—liver cancer	0.00274	0.0101	CcSEcCtD
Nitisinone—Rash maculo-papular—Doxorubicin—liver cancer	0.00265	0.00981	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP2E1—liver cancer	0.00263	0.0038	CbGpPWpGaD
Nitisinone—Hepatic function abnormal—Epirubicin—liver cancer	0.00262	0.00969	CcSEcCtD
Nitisinone—Hepatic failure—Epirubicin—liver cancer	0.00255	0.00942	CcSEcCtD
Nitisinone—Eye pain—Epirubicin—liver cancer	0.00254	0.00938	CcSEcCtD
Nitisinone—Sepsis—Doxorubicin—liver cancer	0.00253	0.00937	CcSEcCtD
Nitisinone—Gastrointestinal pain—Sorafenib—liver cancer	0.00249	0.00921	CcSEcCtD
Nitisinone—HPD—Metabolism—CYCS—liver cancer	0.00246	0.00356	CbGpPWpGaD
Nitisinone—Dermatitis exfoliative—Epirubicin—liver cancer	0.00243	0.00897	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—liver cancer	0.00242	0.00896	CcSEcCtD
Nitisinone—HPD—Metabolism—GOT1—liver cancer	0.00241	0.00349	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GGT1—liver cancer	0.00241	0.00349	CbGpPWpGaD
Nitisinone—Abdominal pain—Sorafenib—liver cancer	0.00241	0.0089	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—liver cancer	0.00236	0.00872	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—liver cancer	0.00235	0.00868	CcSEcCtD
Nitisinone—Hypoglycaemia—Epirubicin—liver cancer	0.00235	0.00868	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00229	0.00847	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00224	0.0083	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—liver cancer	0.00217	0.00803	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTP1—liver cancer	0.00217	0.00314	CbGpPWpGaD
Nitisinone—Pruritus—Sorafenib—liver cancer	0.00215	0.00797	CcSEcCtD
Nitisinone—HPD—Metabolism—HMOX1—liver cancer	0.00214	0.00309	CbGpPWpGaD
Nitisinone—Dehydration—Epirubicin—liver cancer	0.00213	0.00787	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00212	0.00783	CcSEcCtD
Nitisinone—Dry skin—Epirubicin—liver cancer	0.0021	0.00776	CcSEcCtD
Nitisinone—Diarrhoea—Sorafenib—liver cancer	0.00208	0.0077	CcSEcCtD
Nitisinone—Gastritis—Epirubicin—liver cancer	0.00203	0.00749	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTM1—liver cancer	0.00199	0.00288	CbGpPWpGaD
Nitisinone—Dehydration—Doxorubicin—liver cancer	0.00197	0.00729	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—liver cancer	0.00194	0.00718	CcSEcCtD
Nitisinone—Headache—Sorafenib—liver cancer	0.00191	0.00705	CcSEcCtD
Nitisinone—Bronchitis—Epirubicin—liver cancer	0.0019	0.00704	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP1A1—liver cancer	0.00189	0.00273	CbGpPWpGaD
Nitisinone—Gastritis—Doxorubicin—liver cancer	0.00187	0.00693	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—liver cancer	0.00176	0.00651	CcSEcCtD
Nitisinone—HPD—Metabolism—MTHFR—liver cancer	0.00176	0.00255	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PPARA—liver cancer	0.00173	0.0025	CbGpPWpGaD
Nitisinone—Conjunctivitis—Epirubicin—liver cancer	0.00171	0.00634	CcSEcCtD
Nitisinone—Epistaxis—Epirubicin—liver cancer	0.00166	0.00615	CcSEcCtD
Nitisinone—Agranulocytosis—Epirubicin—liver cancer	0.00165	0.00609	CcSEcCtD
Nitisinone—Haemoglobin—Epirubicin—liver cancer	0.00159	0.00589	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—liver cancer	0.00159	0.00587	CcSEcCtD
Nitisinone—Haemorrhage—Epirubicin—liver cancer	0.00158	0.00586	CcSEcCtD
Nitisinone—Epistaxis—Doxorubicin—liver cancer	0.00154	0.00569	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—liver cancer	0.00152	0.00563	CcSEcCtD
Nitisinone—Eye disorder—Epirubicin—liver cancer	0.00148	0.00547	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CG—liver cancer	0.00148	0.00214	CbGpPWpGaD
Nitisinone—Haemoglobin—Doxorubicin—liver cancer	0.00147	0.00545	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—liver cancer	0.00147	0.00542	CcSEcCtD
Nitisinone—HPD—Metabolism—PPARG—liver cancer	0.00143	0.00206	CbGpPWpGaD
Nitisinone—Alopecia—Epirubicin—liver cancer	0.0014	0.00518	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—liver cancer	0.00137	0.00507	CcSEcCtD
Nitisinone—Tension—Epirubicin—liver cancer	0.00135	0.005	CcSEcCtD
Nitisinone—Nervousness—Epirubicin—liver cancer	0.00134	0.00495	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CD—liver cancer	0.0013	0.00188	CbGpPWpGaD
Nitisinone—Alopecia—Doxorubicin—liver cancer	0.00129	0.00479	CcSEcCtD
Nitisinone—HPD—Metabolism—ALB—liver cancer	0.00128	0.00186	CbGpPWpGaD
Nitisinone—Agitation—Epirubicin—liver cancer	0.00127	0.00469	CcSEcCtD
Nitisinone—Tension—Doxorubicin—liver cancer	0.00125	0.00463	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—liver cancer	0.00124	0.00458	CcSEcCtD
Nitisinone—Leukopenia—Epirubicin—liver cancer	0.00123	0.00456	CcSEcCtD
Nitisinone—Convulsion—Epirubicin—liver cancer	0.00119	0.00442	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—liver cancer	0.00117	0.00434	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00117	0.00431	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—liver cancer	0.00114	0.00422	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CB—liver cancer	0.00113	0.00164	CbGpPWpGaD
Nitisinone—Infection—Epirubicin—liver cancer	0.00112	0.00413	CcSEcCtD
Nitisinone—Convulsion—Doxorubicin—liver cancer	0.00111	0.00409	CcSEcCtD
Nitisinone—Thrombocytopenia—Epirubicin—liver cancer	0.0011	0.00407	CcSEcCtD
Nitisinone—Skin disorder—Epirubicin—liver cancer	0.00109	0.00404	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00108	0.00399	CcSEcCtD
Nitisinone—Infection—Doxorubicin—liver cancer	0.00103	0.00383	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—liver cancer	0.00102	0.00377	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—liver cancer	0.00101	0.00374	CcSEcCtD
Nitisinone—Somnolence—Epirubicin—liver cancer	0.001	0.0037	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—liver cancer	0.000926	0.00342	CcSEcCtD
Nitisinone—Gastrointestinal pain—Epirubicin—liver cancer	0.00092	0.0034	CcSEcCtD
Nitisinone—Abdominal pain—Epirubicin—liver cancer	0.000889	0.00329	CcSEcCtD
Nitisinone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000851	0.00315	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—liver cancer	0.000823	0.00304	CcSEcCtD
Nitisinone—Pruritus—Epirubicin—liver cancer	0.000796	0.00294	CcSEcCtD
Nitisinone—Diarrhoea—Epirubicin—liver cancer	0.00077	0.00285	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—liver cancer	0.000737	0.00272	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—liver cancer	0.000712	0.00263	CcSEcCtD
Nitisinone—Headache—Epirubicin—liver cancer	0.000705	0.00261	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CA—liver cancer	0.00069	0.000999	CbGpPWpGaD
Nitisinone—Headache—Doxorubicin—liver cancer	0.000652	0.00241	CcSEcCtD
Nitisinone—HPD—Metabolism—AKT1—liver cancer	0.000564	0.000816	CbGpPWpGaD
